| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.031 | 0.3 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.066 | 0.3 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.032 | 0.3 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |